Project
GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for HOXC8
Z-value: 1.25
Motif logo
Transcription factors associated with HOXC8
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
HOXC8
|
ENSG00000037965.4 | homeobox C8 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| HOXC8 | hg19_v2_chr12_+_54402790_54402832 | -0.34 | 1.8e-07 | Click! |
Activity profile of HOXC8 motif
Sorted Z-values of HOXC8 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chrX_-_109590174 | 24.44 |
ENST00000372054.1
|
GNG5P2
|
guanine nucleotide binding protein (G protein), gamma 5 pseudogene 2 |
| chr8_-_27695552 | 22.95 |
ENST00000522944.1
ENST00000301905.4 |
PBK
|
PDZ binding kinase |
| chrX_+_119737806 | 18.79 |
ENST00000371317.5
|
MCTS1
|
malignant T cell amplified sequence 1 |
| chr3_-_64009658 | 15.72 |
ENST00000394431.2
|
PSMD6
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 6 |
| chr18_+_657578 | 15.41 |
ENST00000323274.10
|
TYMS
|
thymidylate synthetase |
| chr16_-_46655538 | 15.26 |
ENST00000303383.3
|
SHCBP1
|
SHC SH2-domain binding protein 1 |
| chr5_+_159848854 | 14.55 |
ENST00000517480.1
ENST00000520452.1 ENST00000393964.1 |
PTTG1
|
pituitary tumor-transforming 1 |
| chr2_-_89292422 | 13.81 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
| chr2_+_89890533 | 13.37 |
ENST00000429992.2
|
IGKV2D-40
|
immunoglobulin kappa variable 2D-40 |
| chr5_+_135385202 | 13.28 |
ENST00000514554.1
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa |
| chr2_-_89513402 | 13.23 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
| chr1_+_45205478 | 12.73 |
ENST00000452259.1
ENST00000372224.4 |
KIF2C
|
kinesin family member 2C |
| chr7_-_105752971 | 12.52 |
ENST00000011473.2
|
SYPL1
|
synaptophysin-like 1 |
| chr10_+_62538089 | 12.47 |
ENST00000519078.2
ENST00000395284.3 ENST00000316629.4 |
CDK1
|
cyclin-dependent kinase 1 |
| chr12_-_102455846 | 12.33 |
ENST00000545679.1
|
CCDC53
|
coiled-coil domain containing 53 |
| chr2_-_150444116 | 12.13 |
ENST00000428879.1
ENST00000422782.2 |
MMADHC
|
methylmalonic aciduria (cobalamin deficiency) cblD type, with homocystinuria |
| chr2_+_187371440 | 11.88 |
ENST00000445547.1
|
ZC3H15
|
zinc finger CCCH-type containing 15 |
| chr7_-_6523688 | 11.83 |
ENST00000490996.1
|
KDELR2
|
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 |
| chr1_-_149900122 | 11.52 |
ENST00000271628.8
|
SF3B4
|
splicing factor 3b, subunit 4, 49kDa |
| chr15_-_59949693 | 11.46 |
ENST00000396063.1
ENST00000396064.3 ENST00000484743.1 ENST00000559706.1 ENST00000396060.2 |
GTF2A2
|
general transcription factor IIA, 2, 12kDa |
| chr9_+_134065506 | 11.34 |
ENST00000483497.2
|
NUP214
|
nucleoporin 214kDa |
| chr15_-_59949667 | 11.13 |
ENST00000396061.1
|
GTF2A2
|
general transcription factor IIA, 2, 12kDa |
| chr22_+_42017987 | 11.01 |
ENST00000405506.1
|
XRCC6
|
X-ray repair complementing defective repair in Chinese hamster cells 6 |
| chr1_-_225615599 | 10.91 |
ENST00000421383.1
ENST00000272163.4 |
LBR
|
lamin B receptor |
| chr12_-_54652060 | 10.83 |
ENST00000552562.1
|
CBX5
|
chromobox homolog 5 |
| chr1_+_45205498 | 10.78 |
ENST00000372218.4
|
KIF2C
|
kinesin family member 2C |
| chr5_+_172385732 | 10.77 |
ENST00000519974.1
ENST00000521476.1 |
RPL26L1
|
ribosomal protein L26-like 1 |
| chr2_+_90139056 | 10.61 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
| chr2_-_89521942 | 10.55 |
ENST00000482769.1
|
IGKV2-28
|
immunoglobulin kappa variable 2-28 |
| chr10_+_62538248 | 10.30 |
ENST00000448257.2
|
CDK1
|
cyclin-dependent kinase 1 |
| chr4_+_79472673 | 10.23 |
ENST00000264908.6
|
ANXA3
|
annexin A3 |
| chr5_+_167913450 | 10.12 |
ENST00000231572.3
ENST00000538719.1 |
RARS
|
arginyl-tRNA synthetase |
| chr10_+_5135981 | 10.11 |
ENST00000380554.3
|
AKR1C3
|
aldo-keto reductase family 1, member C3 |
| chr15_+_59397275 | 9.93 |
ENST00000288207.2
|
CCNB2
|
cyclin B2 |
| chr2_-_89568263 | 9.84 |
ENST00000473726.1
|
IGKV1-33
|
immunoglobulin kappa variable 1-33 |
| chr11_+_35198118 | 9.80 |
ENST00000525211.1
ENST00000526000.1 ENST00000279452.6 ENST00000527889.1 |
CD44
|
CD44 molecule (Indian blood group) |
| chr1_+_226250379 | 9.67 |
ENST00000366815.3
ENST00000366814.3 |
H3F3A
|
H3 histone, family 3A |
| chr7_-_132766818 | 9.54 |
ENST00000262570.5
|
CHCHD3
|
coiled-coil-helix-coiled-coil-helix domain containing 3 |
| chr7_-_132766800 | 9.54 |
ENST00000542753.1
ENST00000448878.1 |
CHCHD3
|
coiled-coil-helix-coiled-coil-helix domain containing 3 |
| chr5_-_68665084 | 9.42 |
ENST00000509462.1
|
TAF9
|
TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32kDa |
| chrX_-_38080077 | 9.33 |
ENST00000378533.3
ENST00000544439.1 ENST00000432886.2 ENST00000538295.1 |
SRPX
|
sushi-repeat containing protein, X-linked |
| chr1_-_146040968 | 9.32 |
ENST00000401010.3
|
NBPF11
|
neuroblastoma breakpoint family, member 11 |
| chr14_-_107083690 | 9.23 |
ENST00000455737.1
ENST00000390629.2 |
IGHV4-59
|
immunoglobulin heavy variable 4-59 |
| chr2_+_90108504 | 9.21 |
ENST00000390271.2
|
IGKV6D-41
|
immunoglobulin kappa variable 6D-41 (non-functional) |
| chr3_-_149095652 | 9.01 |
ENST00000305366.3
|
TM4SF1
|
transmembrane 4 L six family member 1 |
| chr6_+_63921399 | 9.00 |
ENST00000356170.3
|
FKBP1C
|
FK506 binding protein 1C |
| chr6_+_27114861 | 8.92 |
ENST00000377459.1
|
HIST1H2AH
|
histone cluster 1, H2ah |
| chr14_-_106642049 | 8.84 |
ENST00000390605.2
|
IGHV1-18
|
immunoglobulin heavy variable 1-18 |
| chr12_+_21525818 | 8.78 |
ENST00000240652.3
ENST00000542023.1 ENST00000537593.1 |
IAPP
|
islet amyloid polypeptide |
| chr10_-_58120996 | 8.59 |
ENST00000361148.6
ENST00000395405.1 ENST00000373944.3 |
ZWINT
|
ZW10 interacting kinetochore protein |
| chr13_+_34392185 | 8.49 |
ENST00000380071.3
|
RFC3
|
replication factor C (activator 1) 3, 38kDa |
| chr3_-_141719195 | 8.43 |
ENST00000397991.4
|
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2) |
| chr2_-_176046391 | 8.34 |
ENST00000392541.3
ENST00000409194.1 |
ATP5G3
|
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9) |
| chr16_-_24942411 | 8.32 |
ENST00000571843.1
|
ARHGAP17
|
Rho GTPase activating protein 17 |
| chr11_+_60223225 | 8.27 |
ENST00000524807.1
ENST00000345732.4 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
| chrX_+_48433326 | 8.23 |
ENST00000376755.1
|
RBM3
|
RNA binding motif (RNP1, RRM) protein 3 |
| chr19_-_10697895 | 7.88 |
ENST00000591240.1
ENST00000589684.1 ENST00000591676.1 ENST00000250244.6 ENST00000590923.1 |
AP1M2
|
adaptor-related protein complex 1, mu 2 subunit |
| chr16_-_24942273 | 7.85 |
ENST00000571406.1
|
ARHGAP17
|
Rho GTPase activating protein 17 |
| chr12_+_75874580 | 7.80 |
ENST00000456650.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
| chr12_-_53320245 | 7.60 |
ENST00000552150.1
|
KRT8
|
keratin 8 |
| chr18_+_3252265 | 7.57 |
ENST00000580887.1
ENST00000536605.1 |
MYL12A
|
myosin, light chain 12A, regulatory, non-sarcomeric |
| chr5_+_110074685 | 7.53 |
ENST00000355943.3
ENST00000447245.2 |
SLC25A46
|
solute carrier family 25, member 46 |
| chr2_-_70520539 | 7.50 |
ENST00000482975.2
ENST00000438261.1 |
SNRPG
|
small nuclear ribonucleoprotein polypeptide G |
| chr7_-_87856280 | 7.42 |
ENST00000490437.1
ENST00000431660.1 |
SRI
|
sorcin |
| chr2_+_192109911 | 7.40 |
ENST00000418908.1
ENST00000339514.4 ENST00000392318.3 |
MYO1B
|
myosin IB |
| chr6_-_27114577 | 7.29 |
ENST00000356950.1
ENST00000396891.4 |
HIST1H2BK
|
histone cluster 1, H2bk |
| chr14_-_75643296 | 7.29 |
ENST00000303575.4
|
TMED10
|
transmembrane emp24-like trafficking protein 10 (yeast) |
| chr22_+_23063100 | 7.28 |
ENST00000390309.2
|
IGLV3-19
|
immunoglobulin lambda variable 3-19 |
| chr13_+_53216565 | 7.27 |
ENST00000357495.2
|
HNRNPA1L2
|
heterogeneous nuclear ribonucleoprotein A1-like 2 |
| chr2_-_70520832 | 7.25 |
ENST00000454893.1
ENST00000272348.2 |
SNRPG
|
small nuclear ribonucleoprotein polypeptide G |
| chr2_+_216176540 | 7.23 |
ENST00000236959.9
|
ATIC
|
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase |
| chr1_+_53480598 | 7.16 |
ENST00000430330.2
ENST00000408941.3 ENST00000478274.2 ENST00000484100.1 ENST00000435345.2 ENST00000488965.1 |
SCP2
|
sterol carrier protein 2 |
| chr3_-_64009102 | 7.12 |
ENST00000478185.1
ENST00000482510.1 ENST00000497323.1 ENST00000492933.1 ENST00000295901.4 |
PSMD6
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 6 |
| chr14_-_58894223 | 7.11 |
ENST00000555593.1
|
TIMM9
|
translocase of inner mitochondrial membrane 9 homolog (yeast) |
| chr14_-_106733624 | 7.09 |
ENST00000390610.2
|
IGHV1-24
|
immunoglobulin heavy variable 1-24 |
| chr12_+_104609550 | 7.08 |
ENST00000525566.1
ENST00000429002.2 |
TXNRD1
|
thioredoxin reductase 1 |
| chr7_-_87856303 | 7.07 |
ENST00000394641.3
|
SRI
|
sorcin |
| chr8_-_101718991 | 7.04 |
ENST00000517990.1
|
PABPC1
|
poly(A) binding protein, cytoplasmic 1 |
| chr12_-_102455902 | 7.03 |
ENST00000240079.6
|
CCDC53
|
coiled-coil domain containing 53 |
| chr6_-_159065741 | 7.00 |
ENST00000367085.3
ENST00000367089.3 |
DYNLT1
|
dynein, light chain, Tctex-type 1 |
| chr2_-_20251744 | 6.99 |
ENST00000175091.4
|
LAPTM4A
|
lysosomal protein transmembrane 4 alpha |
| chr2_-_89310012 | 6.94 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
| chr17_-_8113542 | 6.91 |
ENST00000578549.1
ENST00000535053.1 ENST00000582368.1 |
AURKB
|
aurora kinase B |
| chr1_+_224544572 | 6.90 |
ENST00000366857.5
ENST00000366856.3 |
CNIH4
|
cornichon family AMPA receptor auxiliary protein 4 |
| chr4_+_169418195 | 6.90 |
ENST00000261509.6
ENST00000335742.7 |
PALLD
|
palladin, cytoskeletal associated protein |
| chr8_-_101962777 | 6.87 |
ENST00000395951.3
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta |
| chr2_-_24308051 | 6.84 |
ENST00000238721.4
ENST00000335934.4 |
TP53I3
|
tumor protein p53 inducible protein 3 |
| chr1_-_40042416 | 6.80 |
ENST00000372857.3
ENST00000372856.3 ENST00000531243.2 ENST00000451091.2 |
PABPC4
|
poly(A) binding protein, cytoplasmic 4 (inducible form) |
| chr6_+_57037089 | 6.78 |
ENST00000370693.5
|
BAG2
|
BCL2-associated athanogene 2 |
| chr14_+_89060739 | 6.72 |
ENST00000318308.6
|
ZC3H14
|
zinc finger CCCH-type containing 14 |
| chr14_-_106322288 | 6.69 |
ENST00000390559.2
|
IGHM
|
immunoglobulin heavy constant mu |
| chr4_+_83956237 | 6.69 |
ENST00000264389.2
|
COPS4
|
COP9 signalosome subunit 4 |
| chr15_+_66797627 | 6.68 |
ENST00000565627.1
ENST00000564179.1 |
ZWILCH
|
zwilch kinetochore protein |
| chr2_-_89247338 | 6.68 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
| chr2_+_178257372 | 6.67 |
ENST00000264167.4
ENST00000409888.1 |
AGPS
|
alkylglycerone phosphate synthase |
| chr2_-_106054952 | 6.67 |
ENST00000336660.5
ENST00000393352.3 ENST00000607522.1 |
FHL2
|
four and a half LIM domains 2 |
| chr1_+_165864821 | 6.66 |
ENST00000470820.1
|
UCK2
|
uridine-cytidine kinase 2 |
| chr14_-_106926724 | 6.65 |
ENST00000434710.1
|
IGHV3-43
|
immunoglobulin heavy variable 3-43 |
| chr10_+_94352956 | 6.61 |
ENST00000260731.3
|
KIF11
|
kinesin family member 11 |
| chr14_+_89060749 | 6.54 |
ENST00000555900.1
ENST00000406216.3 ENST00000557737.1 |
ZC3H14
|
zinc finger CCCH-type containing 14 |
| chr14_-_106878083 | 6.52 |
ENST00000390619.2
|
IGHV4-39
|
immunoglobulin heavy variable 4-39 |
| chr11_+_60223312 | 6.51 |
ENST00000532491.1
ENST00000532073.1 ENST00000534668.1 ENST00000528313.1 ENST00000533306.1 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
| chr1_+_33116765 | 6.49 |
ENST00000544435.1
ENST00000373485.1 ENST00000458695.2 ENST00000490500.1 ENST00000445722.2 |
RBBP4
|
retinoblastoma binding protein 4 |
| chr11_+_35198243 | 6.44 |
ENST00000528455.1
|
CD44
|
CD44 molecule (Indian blood group) |
| chr14_+_20937538 | 6.41 |
ENST00000361505.5
ENST00000553591.1 |
PNP
|
purine nucleoside phosphorylase |
| chr12_-_10875831 | 6.32 |
ENST00000279550.7
ENST00000228251.4 |
YBX3
|
Y box binding protein 3 |
| chr12_-_65146636 | 6.31 |
ENST00000418919.2
|
GNS
|
glucosamine (N-acetyl)-6-sulfatase |
| chr17_-_55038375 | 6.30 |
ENST00000240316.4
|
COIL
|
coilin |
| chr10_+_13652047 | 6.29 |
ENST00000601460.1
|
RP11-295P9.3
|
Uncharacterized protein |
| chr4_+_69962212 | 6.27 |
ENST00000508661.1
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7 |
| chr8_+_104310661 | 6.26 |
ENST00000522566.1
|
FZD6
|
frizzled family receptor 6 |
| chr17_-_40288449 | 6.21 |
ENST00000552162.1
ENST00000550504.1 |
RAB5C
|
RAB5C, member RAS oncogene family |
| chr19_+_49496705 | 6.17 |
ENST00000595090.1
|
RUVBL2
|
RuvB-like AAA ATPase 2 |
| chr12_+_96252706 | 6.16 |
ENST00000266735.5
ENST00000553192.1 ENST00000552085.1 |
SNRPF
|
small nuclear ribonucleoprotein polypeptide F |
| chr2_-_89459813 | 6.14 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
| chr20_+_1099233 | 6.11 |
ENST00000246015.4
ENST00000335877.6 ENST00000438768.2 |
PSMF1
|
proteasome (prosome, macropain) inhibitor subunit 1 (PI31) |
| chrX_-_16887963 | 6.11 |
ENST00000380084.4
|
RBBP7
|
retinoblastoma binding protein 7 |
| chr14_-_106781017 | 6.09 |
ENST00000390612.2
|
IGHV4-28
|
immunoglobulin heavy variable 4-28 |
| chr2_+_102456277 | 6.06 |
ENST00000421882.1
|
MAP4K4
|
mitogen-activated protein kinase kinase kinase kinase 4 |
| chr14_-_106406090 | 6.04 |
ENST00000390593.2
|
IGHV6-1
|
immunoglobulin heavy variable 6-1 |
| chr15_-_59225758 | 5.98 |
ENST00000558486.1
ENST00000560682.1 ENST00000249736.7 ENST00000559880.1 ENST00000536328.1 |
SLTM
|
SAFB-like, transcription modulator |
| chr1_+_144173162 | 5.97 |
ENST00000356801.6
|
NBPF8
|
neuroblastoma breakpoint family, member 8 |
| chr3_+_151986709 | 5.97 |
ENST00000495875.2
ENST00000493459.1 ENST00000324210.5 ENST00000459747.1 |
MBNL1
|
muscleblind-like splicing regulator 1 |
| chr11_+_101983176 | 5.97 |
ENST00000524575.1
|
YAP1
|
Yes-associated protein 1 |
| chr5_-_68665296 | 5.96 |
ENST00000512152.1
ENST00000503245.1 ENST00000512561.1 ENST00000380822.4 |
TAF9
|
TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32kDa |
| chr6_-_34393825 | 5.95 |
ENST00000605528.1
ENST00000326199.8 |
RPS10-NUDT3
RPS10
|
RPS10-NUDT3 readthrough ribosomal protein S10 |
| chr3_-_81811312 | 5.92 |
ENST00000429644.2
|
GBE1
|
glucan (1,4-alpha-), branching enzyme 1 |
| chr10_+_79793518 | 5.90 |
ENST00000440692.1
ENST00000435275.1 ENST00000372360.3 ENST00000360830.4 |
RPS24
|
ribosomal protein S24 |
| chr8_-_101719159 | 5.86 |
ENST00000520868.1
ENST00000522658.1 |
PABPC1
|
poly(A) binding protein, cytoplasmic 1 |
| chr3_-_189840223 | 5.83 |
ENST00000427335.2
|
LEPREL1
|
leprecan-like 1 |
| chr12_+_117013656 | 5.83 |
ENST00000556529.1
|
MAP1LC3B2
|
microtubule-associated protein 1 light chain 3 beta 2 |
| chr5_+_34757309 | 5.83 |
ENST00000397449.1
|
RAI14
|
retinoic acid induced 14 |
| chr2_-_89399845 | 5.80 |
ENST00000479981.1
|
IGKV1-16
|
immunoglobulin kappa variable 1-16 |
| chr22_-_36924944 | 5.78 |
ENST00000405442.1
ENST00000402116.1 |
EIF3D
|
eukaryotic translation initiation factor 3, subunit D |
| chr2_+_90153696 | 5.78 |
ENST00000417279.2
|
IGKV3D-15
|
immunoglobulin kappa variable 3D-15 (gene/pseudogene) |
| chr9_-_32573130 | 5.78 |
ENST00000350021.2
ENST00000379847.3 |
NDUFB6
|
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa |
| chr6_+_24667257 | 5.75 |
ENST00000537591.1
ENST00000230048.4 |
ACOT13
|
acyl-CoA thioesterase 13 |
| chr14_-_106478603 | 5.68 |
ENST00000390596.2
|
IGHV4-4
|
immunoglobulin heavy variable 4-4 |
| chr4_-_71532339 | 5.68 |
ENST00000254801.4
|
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
| chr15_-_101835110 | 5.68 |
ENST00000560496.1
|
SNRPA1
|
small nuclear ribonucleoprotein polypeptide A' |
| chr17_-_38574169 | 5.65 |
ENST00000423485.1
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa |
| chr12_-_56122220 | 5.64 |
ENST00000552692.1
|
CD63
|
CD63 molecule |
| chr2_-_151344172 | 5.56 |
ENST00000375734.2
ENST00000263895.4 ENST00000454202.1 |
RND3
|
Rho family GTPase 3 |
| chr17_+_66509019 | 5.55 |
ENST00000585981.1
ENST00000589480.1 ENST00000585815.1 |
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha |
| chr9_-_127624194 | 5.50 |
ENST00000373570.4
ENST00000348462.3 |
RPL35
|
ribosomal protein L35 |
| chr1_+_145301735 | 5.50 |
ENST00000605176.1
|
NBPF10
|
neuroblastoma breakpoint family, member 10 |
| chr19_-_14945933 | 5.48 |
ENST00000322301.3
|
OR7A5
|
olfactory receptor, family 7, subfamily A, member 5 |
| chr1_+_158900568 | 5.48 |
ENST00000458222.1
|
PYHIN1
|
pyrin and HIN domain family, member 1 |
| chr17_+_7155819 | 5.48 |
ENST00000570322.1
ENST00000576496.1 ENST00000574841.2 |
ELP5
|
elongator acetyltransferase complex subunit 5 |
| chr2_+_89952792 | 5.46 |
ENST00000390265.2
|
IGKV1D-33
|
immunoglobulin kappa variable 1D-33 |
| chr7_+_116502605 | 5.45 |
ENST00000458284.2
ENST00000490693.1 |
CAPZA2
|
capping protein (actin filament) muscle Z-line, alpha 2 |
| chr18_+_3252206 | 5.45 |
ENST00000578562.2
|
MYL12A
|
myosin, light chain 12A, regulatory, non-sarcomeric |
| chr2_+_201994042 | 5.41 |
ENST00000417748.1
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
| chr2_+_90060377 | 5.41 |
ENST00000436451.2
|
IGKV6D-21
|
immunoglobulin kappa variable 6D-21 (non-functional) |
| chr7_-_7679633 | 5.40 |
ENST00000401447.1
|
RPA3
|
replication protein A3, 14kDa |
| chr6_+_7541845 | 5.39 |
ENST00000418664.2
|
DSP
|
desmoplakin |
| chr10_-_5046042 | 5.38 |
ENST00000421196.3
ENST00000455190.1 |
AKR1C2
|
aldo-keto reductase family 1, member C2 |
| chr4_+_69962185 | 5.35 |
ENST00000305231.7
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7 |
| chr14_+_52456193 | 5.34 |
ENST00000261700.3
|
C14orf166
|
chromosome 14 open reading frame 166 |
| chr11_-_47664072 | 5.32 |
ENST00000542981.1
ENST00000530428.1 ENST00000302503.3 |
MTCH2
|
mitochondrial carrier 2 |
| chr10_-_95241951 | 5.31 |
ENST00000358334.5
ENST00000359263.4 ENST00000371488.3 |
MYOF
|
myoferlin |
| chr15_+_65843130 | 5.28 |
ENST00000569894.1
|
PTPLAD1
|
protein tyrosine phosphatase-like A domain containing 1 |
| chr12_+_75874460 | 5.24 |
ENST00000266659.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
| chr12_+_48357401 | 5.24 |
ENST00000429772.2
ENST00000449758.2 |
TMEM106C
|
transmembrane protein 106C |
| chr1_-_211848899 | 5.24 |
ENST00000366998.3
ENST00000540251.1 ENST00000366999.4 |
NEK2
|
NIMA-related kinase 2 |
| chr14_+_56127989 | 5.23 |
ENST00000555573.1
|
KTN1
|
kinectin 1 (kinesin receptor) |
| chr7_+_107224364 | 5.23 |
ENST00000491150.1
|
BCAP29
|
B-cell receptor-associated protein 29 |
| chr6_-_8102279 | 5.21 |
ENST00000488226.2
|
EEF1E1
|
eukaryotic translation elongation factor 1 epsilon 1 |
| chr1_-_153518270 | 5.21 |
ENST00000354332.4
ENST00000368716.4 |
S100A4
|
S100 calcium binding protein A4 |
| chr11_+_35201826 | 5.20 |
ENST00000531873.1
|
CD44
|
CD44 molecule (Indian blood group) |
| chr2_+_219110149 | 5.17 |
ENST00000456575.1
|
ARPC2
|
actin related protein 2/3 complex, subunit 2, 34kDa |
| chr19_+_30414551 | 5.17 |
ENST00000360605.4
ENST00000570564.1 ENST00000574233.1 ENST00000585655.1 |
URI1
|
URI1, prefoldin-like chaperone |
| chr16_+_33605231 | 5.16 |
ENST00000570121.2
|
IGHV3OR16-12
|
immunoglobulin heavy variable 3/OR16-12 (non-functional) |
| chr2_-_169769787 | 5.15 |
ENST00000451987.1
|
SPC25
|
SPC25, NDC80 kinetochore complex component |
| chr1_-_146082633 | 5.15 |
ENST00000605317.1
ENST00000604938.1 ENST00000339388.5 |
NBPF11
|
neuroblastoma breakpoint family, member 11 |
| chr11_-_10828892 | 5.13 |
ENST00000525681.1
|
EIF4G2
|
eukaryotic translation initiation factor 4 gamma, 2 |
| chr16_+_33006369 | 5.13 |
ENST00000425181.3
|
IGHV3OR16-10
|
immunoglobulin heavy variable 3/OR16-10 (non-functional) |
| chr14_-_106552755 | 5.12 |
ENST00000390600.2
|
IGHV3-9
|
immunoglobulin heavy variable 3-9 |
| chr5_-_10761206 | 5.11 |
ENST00000432074.2
ENST00000230895.6 |
DAP
|
death-associated protein |
| chr12_+_113344755 | 5.07 |
ENST00000550883.1
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
| chr7_+_116502527 | 5.07 |
ENST00000361183.3
|
CAPZA2
|
capping protein (actin filament) muscle Z-line, alpha 2 |
| chr8_+_30244580 | 5.06 |
ENST00000523115.1
ENST00000519647.1 |
RBPMS
|
RNA binding protein with multiple splicing |
| chr10_-_94257512 | 5.05 |
ENST00000371581.5
|
IDE
|
insulin-degrading enzyme |
| chr9_-_95056010 | 5.04 |
ENST00000443024.2
|
IARS
|
isoleucyl-tRNA synthetase |
| chr14_-_106539557 | 5.02 |
ENST00000390599.2
|
IGHV1-8
|
immunoglobulin heavy variable 1-8 |
| chr2_+_120125245 | 5.01 |
ENST00000393103.2
|
DBI
|
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) |
| chr2_-_89340242 | 5.00 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
| chr8_+_55047763 | 4.99 |
ENST00000260102.4
ENST00000519831.1 |
MRPL15
|
mitochondrial ribosomal protein L15 |
| chr1_-_63988846 | 4.98 |
ENST00000283568.8
ENST00000371092.3 ENST00000271002.10 |
ITGB3BP
|
integrin beta 3 binding protein (beta3-endonexin) |
| chr2_-_89630186 | 4.98 |
ENST00000390264.2
|
IGKV2-40
|
immunoglobulin kappa variable 2-40 |
| chr7_+_117824210 | 4.97 |
ENST00000422760.1
ENST00000411938.1 |
NAA38
|
N(alpha)-acetyltransferase 38, NatC auxiliary subunit |
| chr5_-_96518907 | 4.96 |
ENST00000508447.1
ENST00000283109.3 |
RIOK2
|
RIO kinase 2 |
| chr4_+_83956312 | 4.95 |
ENST00000509317.1
ENST00000503682.1 ENST00000511653.1 |
COPS4
|
COP9 signalosome subunit 4 |
| chr2_+_73461410 | 4.94 |
ENST00000399032.2
ENST00000398422.2 ENST00000537131.1 ENST00000538797.1 |
CCT7
|
chaperonin containing TCP1, subunit 7 (eta) |
| chr2_+_73461364 | 4.94 |
ENST00000540468.1
ENST00000539919.1 ENST00000258091.5 |
CCT7
|
chaperonin containing TCP1, subunit 7 (eta) |
| chr2_+_89901292 | 4.92 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
| chr1_-_145827015 | 4.89 |
ENST00000534502.1
ENST00000313835.9 ENST00000454423.3 |
GPR89A
|
G protein-coupled receptor 89A |
| chr14_-_58893832 | 4.87 |
ENST00000556007.2
|
TIMM9
|
translocase of inner mitochondrial membrane 9 homolog (yeast) |
| chr15_-_22473353 | 4.87 |
ENST00000557788.2
|
IGHV4OR15-8
|
immunoglobulin heavy variable 4/OR15-8 (non-functional) |
| chr7_+_107531580 | 4.86 |
ENST00000537148.1
ENST00000440410.1 ENST00000437604.2 |
DLD
|
dihydrolipoamide dehydrogenase |
Network of associatons between targets according to the STRING database.
First level regulatory network of HOXC8
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.3 | 18.8 | GO:0002188 | translation reinitiation(GO:0002188) |
| 5.0 | 19.9 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) |
| 4.8 | 4.8 | GO:0009205 | purine nucleoside triphosphate metabolic process(GO:0009144) purine ribonucleoside triphosphate metabolic process(GO:0009205) |
| 3.6 | 21.5 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
| 3.5 | 24.6 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 3.4 | 10.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 2.9 | 8.7 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 2.9 | 5.8 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 2.8 | 11.2 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 2.7 | 2.7 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) medium-chain fatty acid biosynthetic process(GO:0051792) |
| 2.7 | 11.0 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 2.7 | 21.4 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 2.6 | 12.8 | GO:0042100 | B cell proliferation(GO:0042100) |
| 2.5 | 7.5 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 2.4 | 9.7 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
| 2.4 | 23.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 2.3 | 6.9 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
| 2.2 | 6.7 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 2.1 | 6.4 | GO:0006738 | nicotinamide riboside catabolic process(GO:0006738) inosine metabolic process(GO:0046102) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 1.9 | 1.9 | GO:0035690 | cellular response to drug(GO:0035690) |
| 1.9 | 13.4 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 1.8 | 11.0 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
| 1.8 | 7.2 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 1.7 | 8.5 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 1.7 | 5.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
| 1.7 | 5.1 | GO:1901143 | insulin catabolic process(GO:1901143) |
| 1.7 | 5.0 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 1.7 | 6.7 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 1.7 | 21.5 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 1.7 | 8.3 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 1.6 | 4.8 | GO:1900195 | spindle assembly involved in female meiosis I(GO:0007057) positive regulation of oocyte maturation(GO:1900195) |
| 1.6 | 6.3 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
| 1.6 | 233.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 1.5 | 4.6 | GO:0090244 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) negative regulation of cell fate specification(GO:0009996) Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 1.5 | 4.5 | GO:0002514 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
| 1.5 | 13.6 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 1.5 | 5.8 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 1.4 | 4.3 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 1.4 | 7.2 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
| 1.4 | 12.9 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 1.4 | 7.2 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 1.4 | 8.4 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
| 1.4 | 5.5 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 1.3 | 6.7 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 1.3 | 9.3 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 1.3 | 7.7 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 1.3 | 12.6 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 1.2 | 9.9 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 1.2 | 6.1 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 1.2 | 4.9 | GO:0009106 | lipoate metabolic process(GO:0009106) |
| 1.2 | 4.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 1.2 | 9.5 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 1.2 | 7.0 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 1.2 | 9.3 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 1.1 | 1.1 | GO:0051673 | pore formation in membrane of other organism(GO:0035915) membrane disruption in other organism(GO:0051673) |
| 1.1 | 5.5 | GO:0070980 | biphenyl catabolic process(GO:0070980) |
| 1.1 | 3.2 | GO:0070632 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 1.1 | 11.8 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 1.1 | 3.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 1.0 | 15.5 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
| 1.0 | 13.3 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 1.0 | 3.0 | GO:0097205 | glomerular filtration(GO:0003094) renal filtration(GO:0097205) |
| 1.0 | 3.9 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 1.0 | 8.8 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 1.0 | 6.8 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 1.0 | 5.8 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 1.0 | 3.8 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.9 | 2.8 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.9 | 4.7 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
| 0.9 | 3.7 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.9 | 5.5 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 0.9 | 3.6 | GO:0034476 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
| 0.9 | 3.5 | GO:0019046 | release from viral latency(GO:0019046) |
| 0.8 | 5.0 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.8 | 4.2 | GO:0060337 | response to type I interferon(GO:0034340) type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.8 | 10.0 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.8 | 12.5 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.8 | 2.5 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.8 | 2.4 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.8 | 8.8 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
| 0.8 | 3.2 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.8 | 3.2 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
| 0.8 | 19.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.8 | 1.6 | GO:0001302 | replicative cell aging(GO:0001302) |
| 0.8 | 4.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.8 | 3.9 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.8 | 2.3 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
| 0.8 | 9.9 | GO:1904869 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
| 0.8 | 37.1 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.8 | 9.8 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.8 | 2.3 | GO:1900138 | negative regulation of phospholipase A2 activity(GO:1900138) |
| 0.8 | 36.8 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.7 | 3.7 | GO:0006574 | valine catabolic process(GO:0006574) |
| 0.7 | 6.0 | GO:0060242 | contact inhibition(GO:0060242) |
| 0.7 | 3.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.7 | 17.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.7 | 3.7 | GO:1902775 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.7 | 11.6 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.7 | 4.3 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.7 | 8.6 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.7 | 4.3 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.7 | 4.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.7 | 12.3 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.7 | 4.1 | GO:0030952 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
| 0.7 | 4.7 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.7 | 4.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.7 | 10.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.6 | 2.6 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.6 | 11.8 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
| 0.6 | 1.9 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
| 0.6 | 6.1 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.6 | 2.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.6 | 5.4 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.6 | 11.3 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.6 | 3.0 | GO:1903243 | negative regulation of cardiac muscle adaptation(GO:0010616) transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) negative regulation of lung blood pressure(GO:0061767) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.6 | 1.2 | GO:0002215 | defense response to nematode(GO:0002215) |
| 0.6 | 3.5 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.6 | 5.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.6 | 1.7 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.6 | 9.8 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.6 | 2.9 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.6 | 32.3 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
| 0.6 | 5.6 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
| 0.6 | 3.4 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.6 | 2.8 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.5 | 3.8 | GO:1902962 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.5 | 14.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.5 | 13.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.5 | 1.6 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.5 | 2.6 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.5 | 1.0 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
| 0.5 | 3.1 | GO:0035803 | egg coat formation(GO:0035803) |
| 0.5 | 56.6 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.5 | 4.1 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
| 0.5 | 5.4 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
| 0.5 | 2.5 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
| 0.5 | 2.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.5 | 1.0 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.5 | 8.3 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.5 | 2.9 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.5 | 2.9 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.5 | 6.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.5 | 13.2 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.5 | 77.6 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.5 | 1.9 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.5 | 9.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.4 | 4.5 | GO:0006739 | NADP metabolic process(GO:0006739) |
| 0.4 | 4.5 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.4 | 1.3 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.4 | 1.8 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.4 | 5.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.4 | 1.3 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.4 | 1.7 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.4 | 4.2 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.4 | 1.7 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 0.4 | 5.4 | GO:0070987 | error-free translesion synthesis(GO:0070987) |
| 0.4 | 8.6 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 0.4 | 2.4 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 0.4 | 0.8 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
| 0.4 | 7.3 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 0.4 | 6.8 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
| 0.4 | 3.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.4 | 4.8 | GO:0051775 | response to redox state(GO:0051775) |
| 0.4 | 2.8 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.4 | 4.7 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.4 | 3.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.4 | 6.2 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.4 | 8.2 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.4 | 11.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.4 | 0.4 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
| 0.4 | 1.1 | GO:0070858 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) negative regulation of bile acid biosynthetic process(GO:0070858) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) negative regulation of bile acid metabolic process(GO:1904252) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
| 0.4 | 2.2 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.4 | 6.3 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.4 | 3.0 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
| 0.4 | 6.6 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 0.4 | 2.9 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.4 | 1.8 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.4 | 1.4 | GO:0030047 | actin modification(GO:0030047) |
| 0.4 | 2.5 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
| 0.4 | 47.9 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.4 | 1.1 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) |
| 0.4 | 1.8 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.4 | 2.8 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.3 | 1.7 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.3 | 2.0 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) response to oleic acid(GO:0034201) |
| 0.3 | 3.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.3 | 3.4 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.3 | 2.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.3 | 1.0 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.3 | 9.6 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.3 | 2.6 | GO:0042262 | DNA protection(GO:0042262) |
| 0.3 | 3.6 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.3 | 2.6 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.3 | 6.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.3 | 14.0 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.3 | 0.6 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.3 | 6.0 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.3 | 1.8 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.3 | 21.4 | GO:0034644 | cellular response to UV(GO:0034644) |
| 0.3 | 1.1 | GO:0010976 | positive regulation of neuron projection development(GO:0010976) |
| 0.3 | 1.1 | GO:1904640 | response to methionine(GO:1904640) |
| 0.3 | 10.5 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.3 | 1.4 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.3 | 2.7 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.3 | 1.3 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.3 | 0.8 | GO:0061316 | regulation of Wnt signaling pathway involved in heart development(GO:0003307) arterial endothelial cell fate commitment(GO:0060844) canonical Wnt signaling pathway involved in heart development(GO:0061316) canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) blood vessel lumenization(GO:0072554) positive regulation of ephrin receptor signaling pathway(GO:1901189) regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
| 0.3 | 7.4 | GO:0014904 | myotube cell development(GO:0014904) |
| 0.3 | 6.9 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.3 | 1.8 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.3 | 3.4 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.3 | 4.1 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.3 | 0.8 | GO:0045575 | basophil activation(GO:0045575) |
| 0.2 | 2.7 | GO:0006295 | nucleotide-excision repair, preincision complex stabilization(GO:0006293) nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.2 | 1.5 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
| 0.2 | 2.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.2 | 4.6 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.2 | 3.9 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.2 | 1.7 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
| 0.2 | 1.4 | GO:0009441 | glycolate metabolic process(GO:0009441) |
| 0.2 | 2.9 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.2 | 3.8 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.2 | 0.9 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) negative regulation of cholesterol efflux(GO:0090370) |
| 0.2 | 1.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.2 | 1.8 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.2 | 2.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
| 0.2 | 1.3 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.2 | 0.6 | GO:0043137 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
| 0.2 | 6.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.2 | 1.9 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.2 | 1.0 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.2 | 1.4 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.2 | 5.0 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
| 0.2 | 1.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.2 | 3.3 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.2 | 7.4 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.2 | 12.8 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.2 | 0.4 | GO:1903660 | negative regulation of complement-dependent cytotoxicity(GO:1903660) |
| 0.2 | 4.7 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.2 | 5.0 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.2 | 0.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.2 | 1.1 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
| 0.2 | 1.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.2 | 0.5 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
| 0.2 | 0.9 | GO:0051944 | peptidyl-cysteine methylation(GO:0018125) positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.2 | 0.9 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
| 0.2 | 1.5 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.2 | 1.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.2 | 2.0 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.2 | 2.9 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
| 0.2 | 0.5 | GO:0051685 | maintenance of ER location(GO:0051685) |
| 0.2 | 2.7 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
| 0.2 | 3.4 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
| 0.2 | 5.7 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.2 | 1.3 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.2 | 8.3 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
| 0.2 | 1.5 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
| 0.2 | 0.6 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 0.2 | 1.8 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.2 | 0.8 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
| 0.2 | 3.0 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.2 | 1.6 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.2 | 6.8 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.2 | 0.5 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.2 | 1.5 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 0.1 | 8.2 | GO:0051452 | intracellular pH reduction(GO:0051452) |
| 0.1 | 0.6 | GO:1904796 | regulation of core promoter binding(GO:1904796) |
| 0.1 | 0.7 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.1 | 1.0 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.1 | 1.6 | GO:0060009 | Sertoli cell development(GO:0060009) |
| 0.1 | 3.2 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
| 0.1 | 9.5 | GO:2000177 | regulation of neural precursor cell proliferation(GO:2000177) |
| 0.1 | 1.3 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.1 | 1.1 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.1 | 1.9 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.1 | 0.7 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.1 | 1.0 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
| 0.1 | 0.7 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) glucose 1-phosphate metabolic process(GO:0019255) |
| 0.1 | 1.1 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
| 0.1 | 1.6 | GO:0010658 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) |
| 0.1 | 8.1 | GO:0031100 | organ regeneration(GO:0031100) |
| 0.1 | 1.4 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.1 | 2.8 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 | 0.7 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.1 | 7.6 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.1 | 0.9 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 0.1 | 2.5 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.1 | 3.5 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
| 0.1 | 1.7 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.1 | 0.8 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
| 0.1 | 5.4 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
| 0.1 | 1.1 | GO:1900376 | regulation of melanin biosynthetic process(GO:0048021) positive regulation of melanin biosynthetic process(GO:0048023) regulation of secondary metabolite biosynthetic process(GO:1900376) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
| 0.1 | 2.8 | GO:0006414 | translational elongation(GO:0006414) |
| 0.1 | 5.2 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.1 | 0.6 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.1 | 0.9 | GO:0006772 | thiamine metabolic process(GO:0006772) |
| 0.1 | 0.7 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.1 | 1.1 | GO:0030183 | B cell differentiation(GO:0030183) |
| 0.1 | 1.1 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.1 | 2.4 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.1 | 1.7 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.1 | 3.3 | GO:0014823 | response to activity(GO:0014823) |
| 0.1 | 1.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.1 | 0.7 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 0.1 | 2.8 | GO:0048846 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
| 0.1 | 6.5 | GO:0006342 | chromatin silencing(GO:0006342) |
| 0.1 | 2.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.1 | 2.8 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
| 0.1 | 1.8 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.1 | 2.5 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.1 | 0.2 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) regulation of bone mineralization involved in bone maturation(GO:1900157) negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 0.1 | 4.0 | GO:0046710 | GDP metabolic process(GO:0046710) |
| 0.1 | 0.9 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.1 | 11.7 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
| 0.1 | 0.6 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.1 | 0.5 | GO:0043585 | nose morphogenesis(GO:0043585) alveolar primary septum development(GO:0061143) |
| 0.1 | 0.3 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
| 0.1 | 0.3 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.1 | 0.9 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.1 | 0.2 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.1 | 0.5 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.1 | 2.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
| 0.1 | 0.6 | GO:0030578 | PML body organization(GO:0030578) |
| 0.1 | 0.3 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.1 | 0.3 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 | 8.2 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
| 0.1 | 1.0 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.1 | 0.9 | GO:0002158 | osteoclast proliferation(GO:0002158) pancreatic juice secretion(GO:0030157) |
| 0.1 | 0.8 | GO:0051546 | keratinocyte migration(GO:0051546) |
| 0.1 | 4.2 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.1 | 0.7 | GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition(GO:0051437) |
| 0.1 | 0.8 | GO:0070828 | heterochromatin organization(GO:0070828) |
| 0.1 | 1.1 | GO:0010629 | negative regulation of gene expression(GO:0010629) |
| 0.1 | 0.6 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.1 | 0.9 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
| 0.1 | 1.9 | GO:0030728 | ovulation(GO:0030728) |
| 0.1 | 0.2 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.1 | 2.0 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.1 | 7.4 | GO:0045727 | positive regulation of translation(GO:0045727) |
| 0.1 | 1.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 | 1.2 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
| 0.1 | 0.9 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.1 | 4.2 | GO:0006446 | regulation of translational initiation(GO:0006446) |
| 0.1 | 0.8 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.1 | 1.4 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.1 | 1.9 | GO:1901998 | toxin transport(GO:1901998) |
| 0.1 | 1.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.1 | 1.7 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.1 | 1.1 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
| 0.1 | 1.4 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.1 | 0.7 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 | 0.4 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 0.1 | 0.1 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.1 | 0.5 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
| 0.1 | 0.1 | GO:0014016 | neuroblast differentiation(GO:0014016) |
| 0.1 | 2.7 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
| 0.1 | 1.6 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.1 | 1.8 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
| 0.1 | 0.8 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
| 0.1 | 1.3 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.1 | 0.3 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
| 0.1 | 0.3 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
| 0.1 | 0.2 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.1 | 1.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.1 | 1.8 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.1 | 1.8 | GO:0042246 | tissue regeneration(GO:0042246) |
| 0.1 | 0.2 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.1 | 4.2 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.1 | 4.9 | GO:0019827 | stem cell population maintenance(GO:0019827) maintenance of cell number(GO:0098727) |
| 0.1 | 1.8 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 0.1 | 0.1 | GO:1902994 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
| 0.1 | 0.2 | GO:0002027 | regulation of heart rate(GO:0002027) |
| 0.1 | 4.2 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
| 0.0 | 1.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.0 | 3.2 | GO:0002576 | platelet degranulation(GO:0002576) |
| 0.0 | 0.2 | GO:0007635 | chemosensory behavior(GO:0007635) |
| 0.0 | 0.2 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 0.0 | 2.9 | GO:1903311 | regulation of mRNA metabolic process(GO:1903311) |
| 0.0 | 1.9 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.0 | 0.5 | GO:0045008 | depyrimidination(GO:0045008) |
| 0.0 | 0.7 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.0 | 1.1 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 0.0 | 0.9 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
| 0.0 | 0.1 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.0 | 3.6 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
| 0.0 | 0.8 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.0 | 0.9 | GO:0008210 | estrogen metabolic process(GO:0008210) |
| 0.0 | 0.4 | GO:0042180 | cellular ketone metabolic process(GO:0042180) |
| 0.0 | 0.2 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
| 0.0 | 0.9 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
| 0.0 | 1.6 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.0 | 0.5 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
| 0.0 | 0.4 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.0 | 2.1 | GO:0006401 | RNA catabolic process(GO:0006401) |
| 0.0 | 0.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.0 | 0.2 | GO:0043586 | tongue development(GO:0043586) |
| 0.0 | 2.5 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
| 0.0 | 2.1 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
| 0.0 | 0.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) detection of muscle stretch(GO:0035995) |
| 0.0 | 0.1 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.0 | 0.4 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.0 | 1.1 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
| 0.0 | 0.2 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.0 | 0.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.0 | 0.3 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.0 | 0.9 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
| 0.0 | 0.8 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.0 | 0.4 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 0.0 | 0.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.0 | 0.1 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
| 0.0 | 0.9 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
| 0.0 | 1. |